Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evidence-based clinical practice guidelines for inflammatory bowel disease
Katsuyoshi Matsuoka, Taku Kobayashi, Fumiaki Ueno, et al.
Journal of Gastroenterology (2018) Vol. 53, Iss. 3, pp. 305-353
Open Access | Times Cited: 630

Showing 1-25 of 630 citing articles:

Ulcerative colitis
Taku Kobayashi, Britta Siegmund, Catherine Le Berre, et al.
Nature Reviews Disease Primers (2020) Vol. 6, Iss. 1
Closed Access | Times Cited: 1052
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
Erica J. Brenner, Ryan C. Ungaro, Richard B. Gearry, et al.
Gastroenterology (2020) Vol. 159, Iss. 2, pp. 481-491.e3
Open Access | Times Cited: 668
Phloretin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice by regulating the gut microbiota
Minna Wu, Puze Li, Yunying An, et al.
Pharmacological Research (2019) Vol. 150, pp. 104489-104489
Closed Access | Times Cited: 219
Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis
Jiaqin Liu, Jian Liu, Xiaoliang Tong, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 3255-3276
Open Access | Times Cited: 167
MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis
Dianbo Yao, Wanlin Dai, Ming Dong, et al.
EBioMedicine (2021) Vol. 74, pp. 103751-103751
Open Access | Times Cited: 152
Stress Triggers Flare of Inflammatory Bowel Disease in Children and Adults
Yue Sun, Li Lü, Runxiang Xie, et al.
Frontiers in Pediatrics (2019) Vol. 7
Open Access | Times Cited: 145
Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases
Akihiko Oka, R. Balfour Sartor
Digestive Diseases and Sciences (2020) Vol. 65, Iss. 3, pp. 757-788
Open Access | Times Cited: 144
Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease
Yongjia Hu, Zhouzhou Chen, Chengchen Xu, et al.
Nutrients (2022) Vol. 14, Iss. 23, pp. 5140-5140
Open Access | Times Cited: 71
ROS-responsive nanoparticles for oral delivery of luteolin and targeted therapy of ulcerative colitis by regulating pathological microenvironment
Chen Tan, Heng Fan, Jiahui Ding, et al.
Materials Today Bio (2022) Vol. 14, pp. 100246-100246
Open Access | Times Cited: 70
Wumei Wan attenuates angiogenesis and inflammation by modulating RAGE signaling pathway in IBD: Network pharmacology analysis and experimental evidence
Zheng-lan Duan, Yuji Wang, Zhihua Lü, et al.
Phytomedicine (2023) Vol. 111, pp. 154658-154658
Open Access | Times Cited: 66
Importance of Gut Microbiota in Patients with Inflammatory Bowel Disease
Natalia Ekstedt, Dominika Jamioł-Milc, Joanna Pieczyńska
Nutrients (2024) Vol. 16, Iss. 13, pp. 2092-2092
Open Access | Times Cited: 17
Leucine-rich alpha-2 glycoprotein as a superior biomarker to C-reactive protein for detecting small bowel lesions in Crohn’s disease
Masashi Ohno, Atsushi Nishida, Akinori Otsuki, et al.
World Journal of Gastrointestinal Endoscopy (2025) Vol. 17, Iss. 2
Closed Access | Times Cited: 2
Estimated prevalence of ulcerative colitis and Crohn’s disease in Japan in 2014: an analysis of a nationwide survey
Yoshitaka Murakami, Yuji Nishiwaki, Mari S. Oba, et al.
Journal of Gastroenterology (2019) Vol. 54, Iss. 12, pp. 1070-1077
Closed Access | Times Cited: 123
Zeaxanthin exerts protective effects on acetic acid-induced colitis in rats via modulation of pro-inflammatory cytokines and oxidative stress
Gehan El–Akabawy, Neveen M. El-Sherif
Biomedicine & Pharmacotherapy (2019) Vol. 111, pp. 841-851
Open Access | Times Cited: 114
NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study
Yoichi Kakuta, Yosuke Kawai, Daisuke Okamoto, et al.
Journal of Gastroenterology (2018) Vol. 53, Iss. 9, pp. 1065-1078
Open Access | Times Cited: 104
High-fat diet-derived free fatty acids impair the intestinal immune system and increase sensitivity to intestinal epithelial damage
Shohei Tanaka, Yasuhiro Nemoto, Yuria Takei, et al.
Biochemical and Biophysical Research Communications (2019) Vol. 522, Iss. 4, pp. 971-977
Closed Access | Times Cited: 89
Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα
Hadar Edelman-Klapper, Eran Zittan, Ariella Bar‐Gil Shitrit, et al.
Gastroenterology (2021) Vol. 162, Iss. 2, pp. 454-467
Open Access | Times Cited: 82
Nutrition in Inflammatory Bowel Disease
Philipp Schreiner, Maude Martinho-Grueber, Diana Studerus, et al.
Digestion (2020) Vol. 101, Iss. Suppl. 1, pp. 120-135
Open Access | Times Cited: 78
MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE
C. Rodríguez, Emily Romero, Lourdes Garrido‐Sánchez, et al.
Gut Microbes (2020) Vol. 12, Iss. 1, pp. 1725220-1725220
Open Access | Times Cited: 78
Surgical management of Crohn’s disease: a state of the art review
E. M. van Praag, Christianne J. Buskens, Roel Hompes, et al.
International Journal of Colorectal Disease (2021) Vol. 36, Iss. 6, pp. 1133-1145
Open Access | Times Cited: 77
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases
HoUng Kim, Rieke Alten, Luisa Avedano, et al.
Drugs (2020) Vol. 80, Iss. 2, pp. 99-113
Open Access | Times Cited: 76
The Brain-Gut Axis: Psychological Functioning and Inflammatory Bowel Diseases
Spyros Peppas, Claudia Pansieri, Daniele Piovani, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 3, pp. 377-377
Open Access | Times Cited: 76
Role of interleukin-6-mediated inflammation in the pathogenesis of inflammatory bowel disease: focus on the available therapeutic approaches and gut microbiome
Arshia Shahini, Ali Shahini
Journal of Cell Communication and Signaling (2022) Vol. 17, Iss. 1, pp. 55-74
Open Access | Times Cited: 66
Developments in diagnostic applications of saliva in human organ diseases
Yangyang Cui, Mengying Yang, Jia Zhu, et al.
Medicine in Novel Technology and Devices (2022) Vol. 13, pp. 100115-100115
Open Access | Times Cited: 65
Composition and diverse differences of intestinal microbiota in ulcerative colitis patients
Siying Zhu, Muzhou Han, Simao Liu, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 64
Page 1 - Next Page

Scroll to top